Screening for family members of patients with nasopharyngeal carcinoma.

Screening for family members of patients with nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q50751206
Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinomaHumoral immune responses to Epstein-Barr virus encoded tumor associated proteins and their putative extracellular domains in nasopharyngeal carcinoma patients and regional controls.Seroreactivity against Epstein-Barr virus (EBV) among first-degree relatives of sporadic EBV-associated nasopharyngeal carcinoma in Indonesia.Epstein-Barr virus and rheumatoid arthritis: is there a link?Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families.The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition grooveDried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.Functional polymorphism in the 5'-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma.Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus Zta IgA antibodies in human serum.Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.Potential factors associated with clinical stage of nasopharyngeal carcinoma at diagnosis: a case-control study.Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.An analysis of the efficacy of serial screening for familial nasopharyngeal carcinoma based on Markov chain models.An efficacy analysis for nasopharyngeal carcinoma screening of different screening intervals.
P2860

Screening for family members of patients with nasopharyngeal carcinoma.

Item
http://www.wikidata.org/entity/Q50751206
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Screening for family members of patients with nasopharyngeal carcinoma.
@en
Screening for family members of patients with nasopharyngeal carcinoma.
@nl
type
label
Screening for family members of patients with nasopharyngeal carcinoma.
@en
Screening for family members of patients with nasopharyngeal carcinoma.
@nl
prefLabel
Screening for family members of patients with nasopharyngeal carcinoma.
@en
Screening for family members of patients with nasopharyngeal carcinoma.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Screening for family members of patients with nasopharyngeal carcinoma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698